Call for Papers  

Article Details

Review Article

Cardiac Organoids: A 3D Technology for Disease Modeling and Drug Screening


Yuxin Zhu, Sheng Yang, Tianyi Zhang, Yiling Ge, Xin Wan and Geyu Liang*   Pages 1 - 17 ( 17 )


Cardiovascular diseases remain the leading cause of death worldwide; therefore, there is increasing attention to developing physiological-related in vitro cardiovascular tissue models suitable for personalized healthcare and preclinical test. Recently, more complex and powerful in vitro models have emerged for cardiac research. Human cardiac organoids (HCOs) are three-dimensional (3D) cellular constructs similar to in vivo organs. They are derived from pluripotent stem cells and can replicate the structure, function, and biogenetic information of primitive tissues. High-fidelity HCOs are closer to natural human myocardial tissue than animal and cell models to some extent, which helps to study better the development process of the heart and the occurrence of related diseases. In this review, we introduce the methods for constructing HCOs and the application of them, especially in cardiovascular disease modeling and cardiac drug screening. In addition, we propose the prospects and limitations of HCOs. In summary, we have introduced the research progress of HCOs and described their innovation and practicality of them in the biomedical field.


Cardiac organoid, 3D cultures, disease modeling, drug screening, IPSC, HOCs.


Read Full-Text article